Tags: licensing, pharma trends, Q2
By Raveena Bhambra
Q2 was full of deals, coupled with the talk of potential deals, and overall it finished on a high with a large volume of agreements coming together in June. Read the full story
© 2022 Wildwood Ventures Ltd.